ATC codes:
V03AC01
EMLc
Indication
Other specified sickle cell disorders or other haemoglobinopathies
ICD11 code:
3A51.Y
INN
Deferoxamine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > unspecified:
500 mg in vial powder for injection (mesilate)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended oral deferasirox be specified as a therapeutic alternative under the square box listing for deferoxamine on the EML and EMLc for this indication.